Skip to main content
. 2015 Sep 24;10(9):e0133610. doi: 10.1371/journal.pone.0133610

Fig 1. PTEN and basal phospho-Akt levels in a panel of tumor cell lines.

Fig 1

(A) Immunoblot analysis of PTEN, phospho-Akt (S473), total Akt, and actin in ES, OS, RMS, breast cancer (MCF-7), and prostate cancer (LNCaP) cell lines. (B) Known PI3K and MAPK pathway mutations in cell lines evaluated in A. ES, Ewing sarcoma; ERMS, embryonal rhabdomyosarcoma; DEL, deletion; INS, insertion.